|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM034624988 |
003 |
DE-627 |
005 |
20250126190154.0 |
007 |
tu |
008 |
231221s1987 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0116.xml
|
035 |
|
|
|a (DE-627)NLM034624988
|
035 |
|
|
|a (NLM)3481221
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ober, C
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Prenatal effects of maternal-fetal HLA compatibility
|
264 |
|
1 |
|c 1987
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 18.03.1988
|
500 |
|
|
|a Date Revised 04.04.2017
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Both retrospective studies of idiopathic aborters, as well as prospective studies of normal couples, have shown reduced fertility among couples sharing HLA antigens. However, the effects of maternal-fetal histocompatibility on surviving embryos are largely univestigated. We thus prospectively studied 53 healthy, fertile women whose timed pregnancies were verified within 21 days of conception. Maternal-fetal histocompatibility status was determined for HLA-A,-B, and -DR locus antigens. Fetal growth rates were monitored by ultrasound at 8, 12, and 20 weeks gestation. Neonates were weighed, measured (birthlength, chest circumference, head circumference), and examined within 72 h of delivery (116 major and minor anomalies) in standardized fashion by one of two geneticists. Although no significant differences were found between infants compatible and incompatible at the HLA-A or HLA-B locus, significant differences were observed between HLA-DR compatible and incompatible infants for sex ratios (p less than .003) and minor anomaly rates (p less than .05). Although differences in mean birthweights between HLA-DR compatible and incompatible infants were not significant in this sample, HLA-DR compatible infants were on average 200 grams smaller than HLA-DR incompatible infants. We interpret these findings as evidence for selection against histocompatible fetuses throughout gestation, particularly with respect to HLA-DR compatibility. Potential immunologic and genetic mechanisms are discussed
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Research Support, U.S. Gov't, P.H.S.
|
650 |
|
7 |
|a HLA Antigens
|2 NLM
|
650 |
|
7 |
|a HLA-A Antigens
|2 NLM
|
650 |
|
7 |
|a HLA-B Antigens
|2 NLM
|
650 |
|
7 |
|a HLA-DR Antigens
|2 NLM
|
700 |
1 |
|
|a Simpson, J L
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ward, M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Radvany, R M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Andersen, R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Elias, S
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sabbagha, R
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t American journal of reproductive immunology and microbiology : AJRIM
|d 1985
|g 15(1987), 4 vom: 01. Dez., Seite 141-9
|w (DE-627)NLM023911689
|x 8755-8920
|7 nnns
|
773 |
1 |
8 |
|g volume:15
|g year:1987
|g number:4
|g day:01
|g month:12
|g pages:141-9
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_92
|
912 |
|
|
|a GBV_ILN_110
|
912 |
|
|
|a GBV_ILN_131
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_606
|
912 |
|
|
|a GBV_ILN_657
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_1016
|
951 |
|
|
|a AR
|
952 |
|
|
|d 15
|j 1987
|e 4
|b 01
|c 12
|h 141-9
|